Article Information
History
- November 16, 2021.
Article Versions
- Version 1 (November 4, 2021 - 19:49).
- You are currently viewing Version 2 of this article (November 16, 2021 - 11:25).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- 1Perron Institute for Neurological and Translational Science, Perth, WA 6009, Australia
- 2Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Perth, WA 6150, Australia
- 3Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool L69 3BX, UK
- ↵*Correspondence: sulev.koks{at}perron.uwa.edu.au; Tel.: +61-(0)-8-6457-0313